N-アセチルシステインの市場規模、シェア、成長分析：タイプ別、用途別、地域別 - 産業予測、2025年～2032年

N-アセチルシステインの世界市場規模は2023年に15億米ドルと評価され、2024年の18億4,000万米ドルから2032年には92億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは22.4％で成長する見通しです。

アセチルシステイン（NAT）は、パラセタモールの過剰摂取に対処し、肺炎や気管支炎のような慢性呼吸器疾患における濃い粘液を緩和するための重要な治療薬として機能します。さらに、新生児の乳酸桿菌症の治療にも用いられ、注射、経口摂取、吸入によって投与することができます。栄養補助食品として人気が高まっているが、吐き気、嘔吐、皮膚刺激などの潜在的な副作用に注意する必要があります。アセチルシステインは一般的に妊娠中でも安全と考えられており、有害な分解産物を中和するグルタチオンレベルを上昇させることでパラセタモール毒性と闘う。さらに、吸入すると粘液溶解剤として作用し、粘液の粘度を効果的に低下させる。この多面的な機能性により、アセチルシステインは様々な臨床用途やサプリメント用途において価値ある選択肢として位置づけられています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析

N-アセチルシステイン市場規模：タイプ別& CAGR（2025-2032）

• 市場概要
• 錠剤
• スプレー
• 気管点滴
• その他

N-アセチルシステイン市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 薬
• 栄養補助食品
• その他

N-アセチルシステイン市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Taizhou Tianhong Biochemistry Technology Co., Ltd.（China）
• Zhejiang Kangle Pharmaceutical Co., Ltd.（China）
• Wuhan Wuyao Pharmaceutical Co., Ltd.（China）
• Shijiazhuang Haitian Amino Acid Co., Ltd.（China）
• Jiangsu Gedi Biological Engineering Co., Ltd.（China）
• Nantong Baihua Bio-pharmaceutical Co., Ltd.（China）
• Changzhou Yabang-QH Pharmachem Co., Ltd.（China）
• Anhui Leafchem Co., Ltd.（China）
• Huahai Pharmaceutical Co., Ltd.（China）
• Hebei Guangren Pharmaceutical Technology Co., Ltd.（China）
• Sichuan Mingxin Pharmaceutical Co., Ltd.（China）
• Hangzhou Hyper Chemicals Limited（China）
• Sigma-Aldrich Corporation（USA）
• Alfa Aesar（USA）（now part of Thermo Fisher Scientific, USA）
• Mylan N.V.（USA）（now Viatris Inc., USA）
• Teva Pharmaceutical Industries Ltd.（Israel）
• Hikma Pharmaceuticals PLC（UK）
• NOW Foods（USA）
• Life Extension（USA）

結論と推奨事項

Global N-Acetylcysteine Market size was valued at USD 1.5 billion in 2023 and is poised to grow from USD 1.84 billion in 2024 to USD 9.25 billion by 2032, growing at a CAGR of 22.4% during the forecast period (2025-2032).

Acetylcysteine (NAT) serves as a vital therapeutic agent for addressing paracetamol overdoses and alleviating thick mucus in chronic respiratory conditions like pneumonia and bronchitis. Additionally, it provides treatment for lactobezoar in newborns and can be administered through injection, oral ingestion, or inhalation. While it is increasingly popular as a dietary supplement, users should be aware of potential side effects such as nausea, vomiting, and skin irritation. Acetylcysteine is generally considered safe during pregnancy and combats paracetamol toxicity by elevating glutathione levels, which neutralize harmful breakdown products. Furthermore, when inhaled, it acts as a mucolytic agent, effectively reducing mucus viscosity. This multi-faceted functionality positions acetylcysteine as a valuable option in various clinical and supplemental applications.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global N-Acetylcysteine market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global N-Acetylcysteine Market Segmental Analysis

Global N-Acetylcysteine Market is segmented by Type, Application and region. Based on Type, the market is segmented into Tablet, Spray, Tracheal drip and Other. Based on Application, the market is segmented into Medicines, Nutritional Supplements and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global N-Acetylcysteine Market

The global N-Acetylcysteine market is primarily driven by the increasing demand from the healthcare sector. This antioxidant is recognized for its potential to help prevent cancer and is commonly used in medical settings to treat acetaminophen toxicity by effectively binding to the harmful metabolites produced in the liver. Moreover, N-acetyl cysteine is frequently employed for addressing respiratory conditions, including coughs. While it is also suggested for various other health issues such as the flu and dry eyes, it's important to note that many of these claims lack robust scientific backing. Additionally, its effectiveness in treating COVID-19 remains unproven.

Restraints in the Global N-Acetylcysteine Market

The global N-Acetylcysteine market faces certain restraints primarily due to the potential side effects associated with its use. While N-acetylcysteine is generally well tolerated at lower doses, such as 1,200 mg taken twice daily, some patients may experience uncommon side effects including nausea, vomiting, diarrhea, rashes, flushing, stomach discomfort, and constipation. At significantly higher doses, often utilized for acetaminophen overdose, adverse reactions may occur, such as headaches, tinnitus, hives, chills, fever, and even anaphylactoid responses. Furthermore, N-acetylcysteine can enhance the effects of nitroglycerin and similar medications, necessitating caution in patients at risk of hypotension.

Market Trends of the Global N-Acetylcysteine Market

The Global N-Acetylcysteine (NAC) market is witnessing a notable trend driven by expanding research and clinical applications. Originally recognized for its role as a mucolytic agent and an antidote to acetaminophen overdose, recent studies indicate NAC's potential effectiveness in addressing various health conditions, including mental health disorders and neurological diseases. The ongoing exploration of its benefits in relation to COVID-19 further complements its growing therapeutic portfolio. This broadened scientific inquiry is expected to fuel demand in the pharmaceutical and nutraceutical sectors, positioning NAC as a vital component in modern healthcare and contributing to market growth through 2024 and beyond.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global N-Acetylcysteine Market Size by Type & CAGR (2025-2032)

• Market Overview
• Tablet
• Spray
• Tracheal drip
• Other

Global N-Acetylcysteine Market Size by Application & CAGR (2025-2032)

• Market Overview
• Medicines
• Nutritional Supplements
• Others

Global N-Acetylcysteine Market Size & CAGR (2025-2032)

• North America (Type, Application)
  • US
  • Canada
• Europe (Type, Application)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Application)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Application)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Application)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Taizhou Tianhong Biochemistry Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zhejiang Kangle Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wuhan Wuyao Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shijiazhuang Haitian Amino Acid Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Gedi Biological Engineering Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nantong Baihua Bio-pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Changzhou Yabang-QH Pharmachem Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anhui Leafchem Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Huahai Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hebei Guangren Pharmaceutical Technology Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sichuan Mingxin Pharmaceutical Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hangzhou Hyper Chemicals Limited (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sigma-Aldrich Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Alfa Aesar (USA) (now part of Thermo Fisher Scientific, USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan N.V. (USA) (now Viatris Inc., USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceutical Industries Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hikma Pharmaceuticals PLC (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NOW Foods (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Life Extension (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations